It’s bonkers.” Roche is not a newcomer to the sequencing space: the company bought Jonathan Rothberg’s 454 in 2007 for $140 million. 454 had just announced the completion of Jim Watson’s ...

MiSeq and 454 GS Junior launched by Life Technologies, Illumina and Roche, respectively. Compared to the high-throughput NGS platforms, these benchtop sequencers offer a lower data throughput ...

Researchers at Columbia University, in collaboration with 454, have identified a virus implicated in the deaths of 2.4 million honeybee colonies using the company’s Genome Sequencer™ system. with the ...

Cogenics has launched the 454 Genome Sequencer FLX system at its facility in Meylan, Franceto offer next generation sequencing services. GATC plans to use the Genome Sequencer to offer its customers ...

Currently, there are two main sequencing platforms being used by most research groups: the Roche 454 pyrosequencer (GS, FLX, and FLX Titanium) and the Illumina sequencer (MiSeq and HiSeq2000; Illumina ...

Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of each ...

Basel, 20 February 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) unveiled today its proprietary, breakthrough sequencing by expansion (SBX) technology, establishing a new category of next-generation ...

Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...

Kokoris came up with the idea of solving some of the noise issue of nanopore sequencing by converting DNA into larger surrogate polymers, and he cofounded sequencing company Stratos Genomics back in ...

Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer ...